COVID-19 Impact on Global Commercializing Biomarkers, Market Insights and Forecast to 2026

Published On: Jul 2020

Format: PDF

Publisher: QY Research

Pages: 152

Report ID: 190337

Commercializing Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Commercializing Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Commercializing Biomarkers market is segmented into
Consumables
Services
Software

Segment by Application, the Commercializing Biomarkers market is segmented into
Oncology
Cardiology
Neurology
Others

Regional and Country-level Analysis
The Commercializing Biomarkers market is analysed and market size information is provided by regions (countries).
The key regions covered in the Commercializing Biomarkers market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Commercializing Biomarkers Market Share Analysis
Commercializing Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Commercializing Biomarkers business, the date to enter into the Commercializing Biomarkers market, Commercializing Biomarkers product introduction, recent developments, etc.
The major vendors covered:
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI

1 Study Coverage
1.1 Commercializing Biomarkers Product Introduction
1.2 Market Segments
1.3 Key Commercializing Biomarkers Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Commercializing Biomarkers Market Size Growth Rate by Type
1.4.2 Consumables
1.4.3 Services
1.4.4 Software
1.5 Market by Application
1.5.1 Global Commercializing Biomarkers Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Neurology
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Commercializing Biomarkers Industry Impact
1.6.1 How the Covid-19 is Affecting the Commercializing Biomarkers Industry
1.6.1.1 Commercializing Biomarkers Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Commercializing Biomarkers Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Commercializing Biomarkers Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Commercializing Biomarkers Market Size Estimates and Forecasts
2.1.1 Global Commercializing Biomarkers Revenue 2015-2026
2.1.2 Global Commercializing Biomarkers Sales 2015-2026
2.2 Commercializing Biomarkers Market Size by Region: 2020 Versus 2026
2.2.1 Global Commercializing Biomarkers Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Commercializing Biomarkers Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Commercializing Biomarkers Competitor Landscape by Players
3.1 Commercializing Biomarkers Sales by Manufacturers
3.1.1 Commercializing Biomarkers Sales by Manufacturers (2015-2020)
3.1.2 Commercializing Biomarkers Sales Market Share by Manufacturers (2015-2020)
3.2 Commercializing Biomarkers Revenue by Manufacturers
3.2.1 Commercializing Biomarkers Revenue by Manufacturers (2015-2020)
3.2.2 Commercializing Biomarkers Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Commercializing Biomarkers Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Commercializing Biomarkers Revenue in 2019
3.2.5 Global Commercializing Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Commercializing Biomarkers Price by Manufacturers
3.4 Commercializing Biomarkers Manufacturing Base Distribution, Product Types
3.4.1 Commercializing Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Commercializing Biomarkers Product Type
3.4.3 Date of International Manufacturers Enter into Commercializing Biomarkers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Commercializing Biomarkers Market Size by Type (2015-2020)
4.1.1 Global Commercializing Biomarkers Sales by Type (2015-2020)
4.1.2 Global Commercializing Biomarkers Revenue by Type (2015-2020)
4.1.3 Commercializing Biomarkers Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Commercializing Biomarkers Market Size Forecast by Type (2021-2026)
4.2.1 Global Commercializing Biomarkers Sales Forecast by Type (2021-2026)
4.2.2 Global Commercializing Biomarkers Revenue Forecast by Type (2021-2026)
4.2.3 Commercializing Biomarkers Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Commercializing Biomarkers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
5.1 Global Commercializing Biomarkers Market Size by Application (2015-2020)
5.1.1 Global Commercializing Biomarkers Sales by Application (2015-2020)
5.1.2 Global Commercializing Biomarkers Revenue by Application (2015-2020)
5.1.3 Commercializing Biomarkers Price by Application (2015-2020)
5.2 Commercializing Biomarkers Market Size Forecast by Application (2021-2026)
5.2.1 Global Commercializing Biomarkers Sales Forecast by Application (2021-2026)
5.2.2 Global Commercializing Biomarkers Revenue Forecast by Application (2021-2026)
5.2.3 Global Commercializing Biomarkers Price Forecast by Application (2021-2026)

6 North America
6.1 North America Commercializing Biomarkers by Country
6.1.1 North America Commercializing Biomarkers Sales by Country
6.1.2 North America Commercializing Biomarkers Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Commercializing Biomarkers Market Facts & Figures by Type
6.3 North America Commercializing Biomarkers Market Facts & Figures by Application

7 Europe
7.1 Europe Commercializing Biomarkers by Country
7.1.1 Europe Commercializing Biomarkers Sales by Country
7.1.2 Europe Commercializing Biomarkers Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Commercializing Biomarkers Market Facts & Figures by Type
7.3 Europe Commercializing Biomarkers Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Commercializing Biomarkers by Region
8.1.1 Asia Pacific Commercializing Biomarkers Sales by Region
8.1.2 Asia Pacific Commercializing Biomarkers Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Commercializing Biomarkers Market Facts & Figures by Type
8.3 Asia Pacific Commercializing Biomarkers Market Facts & Figures by Application

9 Latin America
9.1 Latin America Commercializing Biomarkers by Country
9.1.1 Latin America Commercializing Biomarkers Sales by Country
9.1.2 Latin America Commercializing Biomarkers Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Commercializing Biomarkers Market Facts & Figures by Type
9.3 Central & South America Commercializing Biomarkers Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Commercializing Biomarkers by Country
10.1.1 Middle East and Africa Commercializing Biomarkers Sales by Country
10.1.2 Middle East and Africa Commercializing Biomarkers Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Commercializing Biomarkers Market Facts & Figures by Type
10.3 Middle East and Africa Commercializing Biomarkers Market Facts & Figures by Application

11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Commercializing Biomarkers Products Offered
11.1.5 Roche Recent Development
11.2 Dako (Agilent Technologies)
11.2.1 Dako (Agilent Technologies) Corporation Information
11.2.2 Dako (Agilent Technologies) Description, Business Overview and Total Revenue
11.2.3 Dako (Agilent Technologies) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Dako (Agilent Technologies) Commercializing Biomarkers Products Offered
11.2.5 Dako (Agilent Technologies) Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Commercializing Biomarkers Products Offered
11.3.5 Merck Recent Development
11.4 BD
11.4.1 BD Corporation Information
11.4.2 BD Description, Business Overview and Total Revenue
11.4.3 BD Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BD Commercializing Biomarkers Products Offered
11.4.5 BD Recent Development
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description, Business Overview and Total Revenue
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott Commercializing Biomarkers Products Offered
11.5.5 Abbott Recent Development
11.6 Genesys Biolabs (20/20GeneSystems)
11.6.1 Genesys Biolabs (20/20GeneSystems) Corporation Information
11.6.2 Genesys Biolabs (20/20GeneSystems) Description, Business Overview and Total Revenue
11.6.3 Genesys Biolabs (20/20GeneSystems) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Products Offered
11.6.5 Genesys Biolabs (20/20GeneSystems) Recent Development
11.7 Affymetrix
11.7.1 Affymetrix Corporation Information
11.7.2 Affymetrix Description, Business Overview and Total Revenue
11.7.3 Affymetrix Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Affymetrix Commercializing Biomarkers Products Offered
11.7.5 Affymetrix Recent Development
11.8 Agendia
11.8.1 Agendia Corporation Information
11.8.2 Agendia Description, Business Overview and Total Revenue
11.8.3 Agendia Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Agendia Commercializing Biomarkers Products Offered
11.8.5 Agendia Recent Development
11.9 ALMAC
11.9.1 ALMAC Corporation Information
11.9.2 ALMAC Description, Business Overview and Total Revenue
11.9.3 ALMAC Sales, Revenue and Gross Margin (2015-2020)
11.9.4 ALMAC Commercializing Biomarkers Products Offered
11.9.5 ALMAC Recent Development
11.10 Arrayit
11.10.1 Arrayit Corporation Information
11.10.2 Arrayit Description, Business Overview and Total Revenue
11.10.3 Arrayit Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Arrayit Commercializing Biomarkers Products Offered
11.10.5 Arrayit Recent Development
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Commercializing Biomarkers Products Offered
11.1.5 Roche Recent Development
11.12 BG Medicine
11.12.1 BG Medicine Corporation Information
11.12.2 BG Medicine Description, Business Overview and Total Revenue
11.12.3 BG Medicine Sales, Revenue and Gross Margin (2015-2020)
11.12.4 BG Medicine Products Offered
11.12.5 BG Medicine Recent Development
11.13 KEGG EXPRESSION Database
11.13.1 KEGG EXPRESSION Database Corporation Information
11.13.2 KEGG EXPRESSION Database Description, Business Overview and Total Revenue
11.13.3 KEGG EXPRESSION Database Sales, Revenue and Gross Margin (2015-2020)
11.13.4 KEGG EXPRESSION Database Products Offered
11.13.5 KEGG EXPRESSION Database Recent Development
11.14 Thermo Fisher
11.14.1 Thermo Fisher Corporation Information
11.14.2 Thermo Fisher Description, Business Overview and Total Revenue
11.14.3 Thermo Fisher Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Thermo Fisher Products Offered
11.14.5 Thermo Fisher Recent Development
11.15 BGI
11.15.1 BGI Corporation Information
11.15.2 BGI Description, Business Overview and Total Revenue
11.15.3 BGI Sales, Revenue and Gross Margin (2015-2020)
11.15.4 BGI Products Offered
11.15.5 BGI Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Commercializing Biomarkers Market Estimates and Projections by Region
12.1.1 Global Commercializing Biomarkers Sales Forecast by Regions 2021-2026
12.1.2 Global Commercializing Biomarkers Revenue Forecast by Regions 2021-2026
12.2 North America Commercializing Biomarkers Market Size Forecast (2021-2026)
12.2.1 North America: Commercializing Biomarkers Sales Forecast (2021-2026)
12.2.2 North America: Commercializing Biomarkers Revenue Forecast (2021-2026)
12.2.3 North America: Commercializing Biomarkers Market Size Forecast by Country (2021-2026)
12.3 Europe Commercializing Biomarkers Market Size Forecast (2021-2026)
12.3.1 Europe: Commercializing Biomarkers Sales Forecast (2021-2026)
12.3.2 Europe: Commercializing Biomarkers Revenue Forecast (2021-2026)
12.3.3 Europe: Commercializing Biomarkers Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Commercializing Biomarkers Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Commercializing Biomarkers Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Commercializing Biomarkers Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Commercializing Biomarkers Market Size Forecast by Region (2021-2026)
12.5 Latin America Commercializing Biomarkers Market Size Forecast (2021-2026)
12.5.1 Latin America: Commercializing Biomarkers Sales Forecast (2021-2026)
12.5.2 Latin America: Commercializing Biomarkers Revenue Forecast (2021-2026)
12.5.3 Latin America: Commercializing Biomarkers Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Commercializing Biomarkers Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Commercializing Biomarkers Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Commercializing Biomarkers Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Commercializing Biomarkers Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Commercializing Biomarkers Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Commercializing Biomarkers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details